2024 |
Avadel Pharmaceuticals plc - ADR
|
Director and Chief Executive Officer |
7.4 M |
651.1 % |
2023 |
Avadel Pharmaceuticals plc - ADR
|
Director and Chief Executive Officer |
985.2 K |
30.7 % |
2022 |
Avadel Pharmaceuticals plc - ADR
|
Director and Chief Executive Officer |
753.7 K |
-70.2 % |
2021 |
Avadel Pharmaceuticals plc - ADR
|
- |
2.5 M |
-19.5 % |
2021 |
Avadel Pharmaceuticals plc - ADR
|
Director and Chief Executive Officer |
2.5 M |
-19.5 % |
2020 |
Avadel Pharmaceuticals plc - ADR
|
- |
3.1 M |
118.9 % |
2020 |
Avadel Pharmaceuticals plc - ADR
|
Director and Chief Executive Officer |
3.1 M |
118.9 % |
2020 |
Avadel Pharmaceuticals plc - ADR
|
- |
3.1 M |
118.9 % |
2019 |
Avadel Pharmaceuticals plc - ADR
|
- |
1.4 M |
109.5 % |
2019 |
Avadel Pharmaceuticals plc - ADR
|
Director and Chief Executive Officer |
1.4 M |
109.5 % |
2019 |
Avadel Pharmaceuticals plc - ADR
|
- |
1.4 M |
109.5 % |
2018 |
Avadel Pharmaceuticals plc - ADR
|
- |
685.4 K |
-45.7 % |
2018 |
Avadel Pharmaceuticals plc - ADR
|
Interim Chief Executive Officer |
685.4 K |
-45.7 % |
2018 |
Avadel Pharmaceuticals plc - ADR
|
- |
685.4 K |
-45.7 % |
2017 |
Avadel Pharmaceuticals plc - ADR
|
- |
1.3 M |
- |
2017 |
Avadel Pharmaceuticals plc - ADR
|
- |
1.3 M |
- |
2017 |
Avadel Pharmaceuticals plc - ADR
|
Executive Vice President and Chief Commercial Officer |
1.3 M |
- |
2016 |
Avadel Pharmaceuticals plc - ADR
|
- |
885 K |
- |
2016 |
Avadel Pharmaceuticals plc - ADR
|
- |
885 K |
- |
2016 |
Avadel Pharmaceuticals plc - ADR
|
Executive Vice President and Chief Commercial Officer |
- |
- |
2015 |
Avadel Pharmaceuticals plc - ADR
|
Vice President of Corporate and Business Development |
- |
- |